USP should be fine [Dissolution / BCS / IVIVC]

posted by Helmut Homepage – Vienna, Austria, 2019-10-25 00:33 (702 d 04:38 ago) – Posting: # 20726
Views: 1,948

Hi John,

» For ANDA, if the dissolution method for a drug product does not exist in the FDA dissolution database but exists in the USP dissolution database, the USP method is acceptable right?

Yep.

» We've done this before and never had issue from the FDA. Just want know if anyone has experienced push back before.

Two slides of Malcolm Ross (Athens, last November).

[image]

[image]


However, commonly it is the other way ’round. The USP adds methods once they are published in an NDA or ANDA. Malcolm has decades of experience with the FDA… I’ll meet him again in two weeks. Will ask whether he is aware of any problems.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,699 posts in 4,537 threads, 1,542 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 05:11 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5